This week, medtech startup HawkCell, a Lyon-based startup developing a unique MRI plug-and-play solution for veterinary use, announced it has successfully closed Series A funding. Currently, MRI technology for veterinary use is very limited. HawkCell has developed an innovative system incorporating both hardware and software solutions to augment animal MRI imaging.
The system uses patented 3D-printed MRI coils adapted to the morphology of animals to provide the highest quality images and a proprietary animal positioner to decrease the use of anesthesia and reduce risk.
An added layer of AI, applying quantitative and denoising algorithms, reduces image acquisition time while providing unmatched image quality.
The system is manufacturer-agnostic and can adapt any human MRI for animal use, offering both veterinarians and medical researchers better diagnosis, higher efficiency and greater precision.
Importantly, HawkCell adheres to the stringent quality standards of the pharmaceutical industry and the ethical guiding principles for animal research and testing.
The funding round is led by MIG Capital, with participation from a French investment bank.
Alexis Girin, CEO of HawkCell, shared:
“We are thrilled to have the support of MIG Capital, a highly experienced venture fund led by entrepreneurs with a legacy of funding deep tech and life sciences breakthroughs, which shares our mission to narrow the gap between human and veterinary medicine.
Our system has been vetted and approved by experts in AI, neurology, and radiology, and promises to transform veterinary research and care to offer a window into animals’ health with unparalleled clarity.”
Andreas Kastenbauer, Partner at MIG Capital, said:
“The animal health space offers great investment opportunities while helping pets and pet owners achieve a better quality of life.
Veterinary clinics increasingly demand innovative solutions to offer the same quality of treatment and services available to humans.
With its one-of-a-kind imaging solutions for veterinarians and pre-clinical research, HawkCell will change how we understand and care for animals.
We have been impressed by the highly talented and dedicated team with admirable ambitions to transform the future of animal imaging. We are excited to support HawkCell in this new growth phase.”
Lead image: Werkz Luu.
Would you like to write the first comment?
Login to post comments